| 1 | PLA2G7
|
| Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.
|
| Gardner AA, Reichert EC, Topham MK, Stafforini DM.
|
| J Biol Chem 283(25):17099-106. Epub 2008 Apr 22.
2008
|
| 2 | PLA2G7
|
| Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.
|
| Sutton BS, Crosslin DR, Shah SH, Nelson SC, Bassil A, Hale AB, Haynes C, Goldschmidt-Clermont PJ, Vance JM, Seo D, Kraus WE, Gregory SG, Hauser ER.
|
| Hum Mol Genet 17(9):1318-28. Epub 2008 Jan 18. 2008
|
| 3 | PTAFR, PLA2G7
|
| Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
|
| Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, Rupprecht HJ, Cambien F, Blankenberg S, Tiret L.
|
| Hum Mol Genet 13(13):1341-51. Epub 2004 Apr 28. 2004
|
| 4 | PLA2G7
|
| Functional impairment of two novel mutations detected in lipoprotein-associated phospholipase A2 (Lp-PLA2) deficiency patients.
|
| Ishihara M, Iwasaki T, Nagano M, Ishii J, Takano M, Kujiraoka T, Tsuji M, Hattori H, Emi M.
|
| J Hum Genet 49(6):302-7. Epub 2004 May 18. 2004
|
| 5 | PLA2G7
|
| Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages.
|
| Wu X, McIntyre TM, Zimmerman GA, Prescott SM, Stafforini DM.
|
| Biochem J 375(Pt 2):351-63. 2003
|
| 6 | PLA2G7
|
| The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthma.
|
| Kruse S, Mao XQ, Heinzmann A, Blattmann S, Roberts MH, Braun S, Gao PS, Forster J, Kuehr J, Hopkin JM, Shirakawa T, Deichmann KA.
|
| Am J Hum Genet 66(5):1522-30. 2000
|
| 7 | LIS1, PAFAH1B1, PLA2G7
|
| LIS1 is a microtubule-associated phosphoprotein.
|
| Sapir T, Cahana A, Seger R, Nekhai S, Reiner O.
|
| Eur J Biochem 265(1):181-8 1999
|
| 8 | PLA2G7
|
| Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma.
|
| Satoh N, Asano K, Naoki K, Fukunaga K, Iwata M, Kanazawa M, Yamaguchi K.
|
| Am J Respir Crit Care Med 159(3):974-9. 1999
|
| 9 | PLA2G7
|
| Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma.
|
| Stafforini DM, Numao T, Tsodikov A, Vaitkus D, Fukuda T, Watanabe N, Fueki N, McIntyre TM, Zimmerman GA, Makino S, Prescott SM.
|
| J Clin Invest 103(7):989-97. 1999
|
| 10 | LIS1, PAFAH1B1, PLA2G7
|
| Graded reduction of Pafah1b1 (Lis1) activity results in neuronal migration defects and early embryonic lethality.
|
| Hirotsune, S.; Fleck, M. W.; Gambello, M. J.; Bix, G. J.; Chen, A.; Clark, G. D.; Ledbetter, D. H.; McBain, C. J.; Wynshaw-Boris, A
|
| Nat Genet 19 : 333-339. 1998
|
| 11 | LIS1, MDS, PLA2G7
|
| Alteration of the LIS1 gene in Japanese patients with isolated lissencephaly sequence of Miller-Dieker syndrome.
|
| Sakamoto M, et al.
|
| Hum Genet 103 : 586-589. 1998
|
| 12 | DCX, PLA2G7
|
| LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation.
|
| Pilz DT, et al.
|
| Hum Mol Genet 7 : 2029-2037. 1998
|
| 13 | PLA2G7
|
| Association of a G994-->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with genetic susceptibility to nonfamilial dilated cardiomyopathy in Japanese.
|
| Ichihara S, Yamada Y, Yokota M.
|
| Circulation 98(18):1881-5. 1998
|
| 14 | PLA2G7
|
| Identification of the G994--> T missense in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men.
|
| Yamada Y, Ichihara S, Fujimura T, Yokota M.
|
| Metabolism 47(2):177-81. 1998
|
| 15 | LIS1, MDS, PLA2G7
|
| Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome.
|
| Lo Nigro C, et al.
|
| Hum Mol Genet 6 : 157-164. 1997
|
| 16 | LIS1, MDS, PLA2G7, YWHAE
|
| A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3.
|
| Chong SS, et al.
|
| Hum Mol Genet 6 : 147-155. 1997
|
| 17 | PLA2G7
|
| A mutation in plasma platelet-activating factor acetylhydrolase (Val279-->Phe) is a genetic risk factor for stroke.
|
| Hiramoto M, et al.
|
| Stroke 28(12):2417-20 1997
|
| 18 | PLA2G7
|
| Loss of activity of plasma platelet-activating factor acetylhydrolase due to a novel Gln281-->Arg mutation.
|
| Yamada Y, Yokota M.
|
| Biochem Biophys Res Commun 236(3):772-5. 1997
|
| 19 | PLA2G7
|
| Genetics reveals importance of platelet activating factor in asthma and possibly other inflammatory states.
|
| Nadel JA.
|
| J Clin Invest 97 : 2689-2690. 1996
|
| 20 | PLA2G7
|
| Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.
|
| Stafforini DM, et al.
|
| J Clin Invest 97 : 2784-2791. 1996
|
| 21 | PLA2G7
|
| Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins.
|
| Tew DG, et al.
|
| Arterioscler Thromb Vasc Biol 16(4):591-9 1996
|
| 22 | PLA2G7
|
| Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.
|
| Tjoelker LW, et al.
|
| Nature 374(6522):549-53 1995
|
| 23 | LIS1, MDS, PLA2G7
|
| Miller-Dieker lissencephaly gene encodes a subunit of brain platelet-activating factor acetylhydrolase.
|
| Hattori M, et al.
|
| Nature 370 : 216-218. 1994
|